Exacerbation - PDFSEARCH.IO - Document Search Engine

Exacerbation
Results: 215

#	Item
81	FDA ERRATA (dated[removed]To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING April 7, 2010 NDA[removed]: Daxas (roflumilast 500 mcg tablets) Add to Reading List Source URL: www.fda.gov Language: English Medicine Chemistry Benzamides Organofluorides Pyridines Roflumilast Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Chronic bronchitis Health Chronic lower respiratory diseases Smoking
82	Microsoft Word - Comments on FDA Briefing Document Oct 30.doc Add to Reading List Source URL: www.fda.gov Language: English Health Acute exacerbation of chronic obstructive pulmonary disease Tiotropium bromide Medicine Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking
83	SPIRIVA HandiHaler (tiotropium bromide inhalation powder) NDA # [removed]s029 Add to Reading List Source URL: www.fda.gov Language: English Chronic lower respiratory diseases Smoking Muscarinic antagonists Thiophenes Epoxides Tiotropium bromide Respimat Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Medicine Health Pulmonology
84	Daxas® (roflumilast) Tablets NDA[removed]Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010 Add to Reading List Source URL: www.fda.gov Language: English Medicine Chemistry Chronic obstructive pulmonary disease Roflumilast Acute exacerbation of chronic obstructive pulmonary disease Chronic bronchitis Long-acting beta-adrenoceptor agonist Chronic Health Chronic lower respiratory diseases Smoking
85	FDA ERRATA To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING March 8, 2011 NDA[removed]Indacaterol maleate (Arcapta Neohaler) for the long-term, once-daily, maintenance treatm Add to Reading List Source URL: www.fda.gov Language: English Pulmonology Respiratory therapy Acute exacerbation of chronic obstructive pulmonary disease Chronic obstructive pulmonary disease Indacaterol Chronic bronchitis Acute exacerbations of chronic bronchitis Tiotropium bromide Chronic lower respiratory diseases Smoking Health
86	Table of Contents I. Division Memorandum II. Add to Reading List Source URL: www.fda.gov Language: English Muscarinic antagonists Bronchodilators Chronic lower respiratory diseases Pulmonary function testing Tiotropium bromide Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Asthma Spirometry Pulmonology Medicine Respiratory therapy
87	Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) is a slow progressive lung disease that includes chronic bronchitis and emphysema. Tobacco smoking is the leading cause of COPD, a Add to Reading List Source URL: www.communitycarenc.com Language: English - Date: 2011-06-17 16:10:56 Respiratory therapy Chronic lower respiratory diseases Smoking Pulmonary function testing Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Pulmonary rehabilitation Disease management Asthma Medicine Pulmonology Health
88	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 www.novartis.ca http://www.novartis.com Add to Reading List Source URL: www.novartis.ca Language: English - Date: 2014-11-17 07:51:05 Chronic lower respiratory diseases Pulmonary function testing Smoking Respiratory physiology Obstructive lung disease Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Indacaterol Long-acting beta-adrenoceptor agonist Pulmonology Medicine Respiratory therapy
89	US Food and Drug Administration Meeting of the Pulmonary-Allergy Drugs Advisory Committee November 19, 2009 Badrul A. Chowdhury, MD, PhD Add to Reading List Source URL: www.fda.gov Language: English Bronchodilators Epoxides Thiophenes Tiotropium bromide Respimat Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Stroke Aging-associated diseases Medicine Health
90	FDA Advisory Committee Briefing Document: BREO ELLIPTA (Fluticasone Furoate/Vilanterol Inhalation Powder) for Treatment of COPD Add to Reading List Source URL: www.fda.gov Language: English Respiratory therapy Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking Asthma Spirometry Acute exacerbation of chronic obstructive pulmonary disease Clinical trial Pulmonology Medicine Health

UPDATE